Why the study?
Do the ANGPTL4 E40K and T266M variants affect plasma triglyceride levels and the risk of coronary heart disease?
Do the ANGPTL4 E40K and T266M variants affect plasma triglyceride levels and the risk of coronary heart disease?
Although the ANGPTL4 E40K variant is associated with an atheroprotective lipid profile (lower triglycerides), it paradoxically increases the risk of coronary heart disease, suggesting effects beyond lipid modulation.
Answers are grounded in this paper and cite their sources.
Paradoxical CHD risk elevation despite lower triglycerides with E40K; leaves open non-lipid mechanisms and should not yet guide ANGPTL4-targeted therapy.
BACKGROUND: Angiopoietin-like 4 is a dual-function protein: an inhibitor of LPL, influencing plasma triglycerides (TGs), with angiogenic properties. We examined the association of common ANGPTL4 variants with CHD traits and risk in 5 studies (13,527 individuals). METHODS AND RESULTS: The effects on plasma lipids of 6 tagging SNPs and the recently identified E40K were examined in a study of 2772 men. Only T266M (rs1044250, MAF=30%) and E40K (MAF=2%) were significantly associated with TG-lowering (-10.4%, P<0.004 and -20.4%, P<0.0001), respectively. T266M no longer showed significant associations when K40 carriers (K40+) were excluded (P=0.2). Combining data from 5 studies confirmed the TG-lowering effect of K40+ (weighted mean difference: -0.12 [95% CI -0.18, -0.05] mmol/L TG P=0.0001). Surprisingly, in the 3 prospective studies, the combined OR for CHD was 1.48 (1.11 to 1.96, P=0.007), independent of TG. In individuals with a paternal history of MI (n=332) T266M, but not E40K, showed effects on postprandial AUC TG and glucose (P=0.009 and P=0.017, respectively) compared to controls (n=370). CONCLUSIONS: Although associated with an atheroprotective lipid profile, E40K was associated with increased CHD risk, suggesting Angptl4 influences parameters beyond lipid levels. T266M showed effects only under conditions of postprandial stress. The functionality of these potential "loss-of-function" variants needs validation.
No takes yet. Share an insight, caveat, or question.
Talmud et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: